Luye Pharma Group Ltd

02186

Company Profile

  • Business description

    Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on development, production, marketing and sale of pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company’s highest revenue share comes from oncology drugs, followed by central nervous system drugs. The company develops drugs for world-wide use in Asia, Europe, and the United States. The Group organizes its business segments by type of products. Oncology drugs, Cardiovascular system drugs, Alimentary tract and metabolism drugs and Central nervous system drugs. It derives maximum revenue from the sale of Oncology drugs.

  • Contact

    Hongqiao Road 1438
    22/F, Gubei International Fortune Center II
    Changning District
    Shanghai264003
    CHN

    T: +86 2162376350

    https://www.luye.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    5,234

Stocks News & Analysis

stocks

2 undervalued ASX shares report

These two ASX shares are trading at a discount to our fair value. 
stocks

Turmoil at WiseTech

Board members step down over differences on the role of former CEO Richard White.
video

What does the RBA rate cut mean for investors?

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,498.0062.10-0.73%
CAC 408,090.9963.52-0.78%
DAX 4022,425.93138.370.62%
Dow JONES (US)43,461.2133.190.08%
FTSE 1008,658.980.39-0.00%
HKSE23,227.63113.98-0.49%
NASDAQ19,286.93237.08-1.21%
Nikkei 22538,281.45495.49-1.28%
NZX 50 Index12,307.27224.45-1.79%
S&P 5005,983.2529.88-0.50%
S&P/ASX 2008,251.9056.30-0.68%
SSE Composite Index3,367.255.77-0.17%

Market Movers